Received May 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | Y49BZ | IM / RL |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | BM4R5 | IM / LL |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y01464 | SC / LL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 2 | MF0415 | IM / RL |
The patient received a dose of Kinrix at too early of an age. She did not show any adverse symptoms or side effects after receiving the vaccine.
No medical tests or laboratory results were collected that were related to the adverse event.